Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. The active substance of the balloon is highly lipophilic in nature. Drug eluting balloon homogeneously delivers the drug to the vessel and prevents neointimal hyperplasia (proliferation of vascular smooth muscle and thickening of arterial wall, thus reducing the arterial lumen space). The device has gained popularity as it helps in effective treatment of in-stent restenosis as compared to drug eluting stent or bare metal stent. Rise in peripheral and coronary artery diseases among the geriatric population is likely to drive the global drug eluting balloon market in the near future.
In 2019, the market size of Drug-Eluting Balloons is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Balloons.
This report studies the global market size of Drug-Eluting Balloons, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug-Eluting Balloons production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
Market Segment by Product Type
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
Market Segment by Application
Hospitals and Ambulatory Surgery Centers
CATH Labs
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug-Eluting Balloons status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug-Eluting Balloons manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug-Eluting Balloons are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Drug-Eluting Balloons is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Balloons.
This report studies the global market size of Drug-Eluting Balloons, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Drug-Eluting Balloons production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
Market Segment by Product Type
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
Market Segment by Application
Hospitals and Ambulatory Surgery Centers
CATH Labs
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Drug-Eluting Balloons status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Drug-Eluting Balloons manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Drug-Eluting Balloons are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Drug-Eluting Balloons Market Size Growth Rate by Type (2019-2025)
1.3.2 Coronary Drug Eluting Balloon
1.3.3 Peripheral Drug Eluting Balloon
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Drug-Eluting Balloons Market Share by Application (2019-2025)
1.4.2 Hospitals and Ambulatory Surgery Centers
1.4.3 CATH Labs
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Drug-Eluting Balloons Production Value 2014-2025
2.1.2 Global Drug-Eluting Balloons Production 2014-2025
2.1.3 Global Drug-Eluting Balloons Capacity 2014-2025
2.1.4 Global Drug-Eluting Balloons Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Drug-Eluting Balloons Market Size CAGR of Key Regions
2.2.2 Global Drug-Eluting Balloons Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Drug-Eluting Balloons Capacity by Manufacturers
3.1.2 Global Drug-Eluting Balloons Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Drug-Eluting Balloons Revenue by Manufacturers (2014-2019)
3.2.2 Drug-Eluting Balloons Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Drug-Eluting Balloons Market Concentration Ratio (CR5 and HHI)
3.3 Drug-Eluting Balloons Price by Manufacturers
3.4 Key Manufacturers Drug-Eluting Balloons Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Drug-Eluting Balloons Market
3.6 Key Manufacturers Drug-Eluting Balloons Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Coronary Drug Eluting Balloon Production and Production Value (2014-2019)
4.1.2 Peripheral Drug Eluting Balloon Production and Production Value (2014-2019)
4.1.3 Others Production and Production Value (2014-2019)
4.2 Global Drug-Eluting Balloons Production Market Share by Type
4.3 Global Drug-Eluting Balloons Production Value Market Share by Type
4.4 Drug-Eluting Balloons Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Drug-Eluting Balloons Consumption by Application
6 Production by Regions
6.1 Global Drug-Eluting Balloons Production (History Data) by Regions 2014-2019
6.2 Global Drug-Eluting Balloons Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Drug-Eluting Balloons Production Growth Rate 2014-2019
6.3.2 United States Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Drug-Eluting Balloons Import & Export
6.4 European Union
6.4.1 European Union Drug-Eluting Balloons Production Growth Rate 2014-2019
6.4.2 European Union Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Drug-Eluting Balloons Import & Export
6.5 China
6.5.1 China Drug-Eluting Balloons Production Growth Rate 2014-2019
6.5.2 China Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Drug-Eluting Balloons Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Drug-Eluting Balloons Consumption by Regions
7.1 Global Drug-Eluting Balloons Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Drug-Eluting Balloons Consumption by Type
7.2.2 United States Drug-Eluting Balloons Consumption by Application
7.3 European Union
7.3.1 European Union Drug-Eluting Balloons Consumption by Type
7.3.2 European Union Drug-Eluting Balloons Consumption by Application
7.4 China
7.4.1 China Drug-Eluting Balloons Consumption by Type
7.4.2 China Drug-Eluting Balloons Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Drug-Eluting Balloons Consumption by Type
7.5.2 Rest of World Drug-Eluting Balloons Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Boston Scientific
8.1.1 Boston Scientific Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Drug-Eluting Balloons
8.1.4 Drug-Eluting Balloons Product Introduction
8.1.5 Boston Scientific Recent Development
8.2 Medtronic
8.2.1 Medtronic Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Drug-Eluting Balloons
8.2.4 Drug-Eluting Balloons Product Introduction
8.2.5 Medtronic Recent Development
8.3 Cook Medical
8.3.1 Cook Medical Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Drug-Eluting Balloons
8.3.4 Drug-Eluting Balloons Product Introduction
8.3.5 Cook Medical Recent Development
8.4 C.R. Bard
8.4.1 C.R. Bard Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Drug-Eluting Balloons
8.4.4 Drug-Eluting Balloons Product Introduction
8.4.5 C.R. Bard Recent Development
8.5 B. Braun
8.5.1 B. Braun Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Drug-Eluting Balloons
8.5.4 Drug-Eluting Balloons Product Introduction
8.5.5 B. Braun Recent Development
8.6 Eurocor GmbH
8.6.1 Eurocor GmbH Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Drug-Eluting Balloons
8.6.4 Drug-Eluting Balloons Product Introduction
8.6.5 Eurocor GmbH Recent Development
8.7 Blue Medical
8.7.1 Blue Medical Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Drug-Eluting Balloons
8.7.4 Drug-Eluting Balloons Product Introduction
8.7.5 Blue Medical Recent Development
8.8 Bayer
8.8.1 Bayer Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Drug-Eluting Balloons
8.8.4 Drug-Eluting Balloons Product Introduction
8.8.5 Bayer Recent Development
8.9 Aachen Resonance
8.9.1 Aachen Resonance Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Drug-Eluting Balloons
8.9.4 Drug-Eluting Balloons Product Introduction
8.9.5 Aachen Resonance Recent Development
8.10 Acrostak
8.10.1 Acrostak Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Drug-Eluting Balloons
8.10.4 Drug-Eluting Balloons Product Introduction
8.10.5 Acrostak Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Drug-Eluting Balloons Capacity, Production Forecast 2019-2025
9.1.2 Global Drug-Eluting Balloons Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Drug-Eluting Balloons Production and Value Forecast by Regions 2019-2025
9.2.2 Global Drug-Eluting Balloons Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Drug-Eluting Balloons Production Forecast by Type
9.7.2 Global Drug-Eluting Balloons Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Drug-Eluting Balloons Sales Channels
10.2.2 Drug-Eluting Balloons Distributors
10.3 Drug-Eluting Balloons Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Drug-Eluting Balloons Market Size Growth Rate by Type (2019-2025)
1.3.2 Coronary Drug Eluting Balloon
1.3.3 Peripheral Drug Eluting Balloon
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Drug-Eluting Balloons Market Share by Application (2019-2025)
1.4.2 Hospitals and Ambulatory Surgery Centers
1.4.3 CATH Labs
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Drug-Eluting Balloons Production Value 2014-2025
2.1.2 Global Drug-Eluting Balloons Production 2014-2025
2.1.3 Global Drug-Eluting Balloons Capacity 2014-2025
2.1.4 Global Drug-Eluting Balloons Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Drug-Eluting Balloons Market Size CAGR of Key Regions
2.2.2 Global Drug-Eluting Balloons Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Drug-Eluting Balloons Capacity by Manufacturers
3.1.2 Global Drug-Eluting Balloons Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Drug-Eluting Balloons Revenue by Manufacturers (2014-2019)
3.2.2 Drug-Eluting Balloons Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Drug-Eluting Balloons Market Concentration Ratio (CR5 and HHI)
3.3 Drug-Eluting Balloons Price by Manufacturers
3.4 Key Manufacturers Drug-Eluting Balloons Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Drug-Eluting Balloons Market
3.6 Key Manufacturers Drug-Eluting Balloons Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Coronary Drug Eluting Balloon Production and Production Value (2014-2019)
4.1.2 Peripheral Drug Eluting Balloon Production and Production Value (2014-2019)
4.1.3 Others Production and Production Value (2014-2019)
4.2 Global Drug-Eluting Balloons Production Market Share by Type
4.3 Global Drug-Eluting Balloons Production Value Market Share by Type
4.4 Drug-Eluting Balloons Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Drug-Eluting Balloons Consumption by Application
6 Production by Regions
6.1 Global Drug-Eluting Balloons Production (History Data) by Regions 2014-2019
6.2 Global Drug-Eluting Balloons Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Drug-Eluting Balloons Production Growth Rate 2014-2019
6.3.2 United States Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Drug-Eluting Balloons Import & Export
6.4 European Union
6.4.1 European Union Drug-Eluting Balloons Production Growth Rate 2014-2019
6.4.2 European Union Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Drug-Eluting Balloons Import & Export
6.5 China
6.5.1 China Drug-Eluting Balloons Production Growth Rate 2014-2019
6.5.2 China Drug-Eluting Balloons Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Drug-Eluting Balloons Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Drug-Eluting Balloons Consumption by Regions
7.1 Global Drug-Eluting Balloons Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Drug-Eluting Balloons Consumption by Type
7.2.2 United States Drug-Eluting Balloons Consumption by Application
7.3 European Union
7.3.1 European Union Drug-Eluting Balloons Consumption by Type
7.3.2 European Union Drug-Eluting Balloons Consumption by Application
7.4 China
7.4.1 China Drug-Eluting Balloons Consumption by Type
7.4.2 China Drug-Eluting Balloons Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Drug-Eluting Balloons Consumption by Type
7.5.2 Rest of World Drug-Eluting Balloons Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Boston Scientific
8.1.1 Boston Scientific Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Drug-Eluting Balloons
8.1.4 Drug-Eluting Balloons Product Introduction
8.1.5 Boston Scientific Recent Development
8.2 Medtronic
8.2.1 Medtronic Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Drug-Eluting Balloons
8.2.4 Drug-Eluting Balloons Product Introduction
8.2.5 Medtronic Recent Development
8.3 Cook Medical
8.3.1 Cook Medical Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Drug-Eluting Balloons
8.3.4 Drug-Eluting Balloons Product Introduction
8.3.5 Cook Medical Recent Development
8.4 C.R. Bard
8.4.1 C.R. Bard Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Drug-Eluting Balloons
8.4.4 Drug-Eluting Balloons Product Introduction
8.4.5 C.R. Bard Recent Development
8.5 B. Braun
8.5.1 B. Braun Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Drug-Eluting Balloons
8.5.4 Drug-Eluting Balloons Product Introduction
8.5.5 B. Braun Recent Development
8.6 Eurocor GmbH
8.6.1 Eurocor GmbH Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Drug-Eluting Balloons
8.6.4 Drug-Eluting Balloons Product Introduction
8.6.5 Eurocor GmbH Recent Development
8.7 Blue Medical
8.7.1 Blue Medical Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Drug-Eluting Balloons
8.7.4 Drug-Eluting Balloons Product Introduction
8.7.5 Blue Medical Recent Development
8.8 Bayer
8.8.1 Bayer Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Drug-Eluting Balloons
8.8.4 Drug-Eluting Balloons Product Introduction
8.8.5 Bayer Recent Development
8.9 Aachen Resonance
8.9.1 Aachen Resonance Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Drug-Eluting Balloons
8.9.4 Drug-Eluting Balloons Product Introduction
8.9.5 Aachen Resonance Recent Development
8.10 Acrostak
8.10.1 Acrostak Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Drug-Eluting Balloons
8.10.4 Drug-Eluting Balloons Product Introduction
8.10.5 Acrostak Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Drug-Eluting Balloons Capacity, Production Forecast 2019-2025
9.1.2 Global Drug-Eluting Balloons Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Drug-Eluting Balloons Production and Value Forecast by Regions 2019-2025
9.2.2 Global Drug-Eluting Balloons Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Drug-Eluting Balloons Production Forecast by Type
9.7.2 Global Drug-Eluting Balloons Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Drug-Eluting Balloons Sales Channels
10.2.2 Drug-Eluting Balloons Distributors
10.3 Drug-Eluting Balloons Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
